MRI Evaluation of the Breast Areolar Margin and Paryenchyma

NCT01300585 | Terminated

• 1 other identifier: Breast MRI
• Study Type: interventional
• Target: 68
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to test a new method of defining patterns of how breast glands are or are not attached to the overlying skin. All patients will have markers placed on both breasts and will undergo an MRI. MRI results will be examined to identify the pattern of breast gland attachment to the overlying skin. This will help identify patients which may benefit from areolar sparing and/or nipple sparing technique and which patients should be treated by standard mastectomy.

Conditions

Breast Cancer

Keywords

Breast; Cancer

Outcome Measures

Primary Outcomes (1)

• Patterns of Breast Gland Attachment

  Identify the various patterns of breast gland attachment to the overlying skin.

  6 months

Study Arms (1)

MRI

OTHER

All patients on study will undergo an MRI of the breast(s).

Other: MRI

Interventions

MRI OTHER

Patients who qualify for the study and consent to be included will undergo placement of areola and nipple markers that will be held in place with tape for the duration of the ordered MRI study. The markers consist of latex-free plastic tubing filled with vegetable based hydrogenated oil that is solid at room temperature. This creates a fat density marker that will define the areola but does not interfere with or create artifact onto the underlying tissue. The marker can be placed by the investigator or available MRI technician instructed in marker placement. The patient will then undergo the MRI. The patients participation in the study will end with the MRI.

MRI

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Have one of the following indications for MRI study of the breast - screening for high risk without evidence of disease, have existing breast cancer with need for evaluation of extent of disease or to rule out additional occult cancer, or to have an equivocal mammogram or ultrasound requiring additional information from MRI.
• No prior breast surgery including prior excisional biopsies for disease performed with surgical technique, breast augmentation, reduction mammoplasty or breast lift with or without implants.
• Capable of fitting into the MRI machine.
• Permission to contact and consent the patient to participate from the investigator(s)
• Provide written informed consent and Authorization for Use/Disclosure of PHI

You may not qualify if:

• Have a contraindication to MRI study.
• Prior breast surgery - this includes: prior excisional biopsies for disease performed with surgical technique, breast augmentation, reduction mammoplasty or breast lift with or without implants \[Patients may have undergone prior percutaneous (needle) biopsy or fine needle aspiration\]
• Inability to fit into the MRI machine.
• Psychological factors that may interfere with successful completion of the study
• Refusal to provide written informed consent and/or Authorization for Use/Disclosure of PHI

Sponsors & Collaborators

• Piedmont Healthcare: lead

Study Sites (1)

Piedmont Hospital

Atlanta, Georgia, 30309, United States

Location

MeSH Terms

Conditions

Breast Neoplasms; Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Heather Richardson, MD

  Piedmont Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 17, 2011
• First Posted: February 21, 2011
• Study Start: February 1, 2011
• Primary Completion: May 1, 2014
• Study Completion: May 1, 2014
• Last Updated: May 5, 2014

Record last verified: 2014-05

Locations

US (1)